| Ze Ouyang,Weili Tao,Shiying Yu,Man Zou. Advances in pharmacotherapies in cancer-related cachexia. Oncol Transl Med, 2023, 9: 15-21. |
| Advances in pharmacotherapies in cancer-related cachexia |
| Received:November 04, 2022 Revised:February 27, 2023 |
| View Full Text View/Add Comment Download reader |
| KeyWord:cancer; cachexia; muscle wasting; mechanism; drug therapy |
| Author Name | Affiliation | E-mail | | Ze Ouyang | Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology | ouyz20@163.com | | Weili Tao | Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology | | | Shiying Yu | Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology | | | Man Zou | Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology | skyfountain@163.com |
|
| Hits: 1587 |
| Download times: 1804 |
| Abstract: |
| Cancer-related cachexia is highly prevalent in patients with advanced cancer, affecting approximately 50%–
80% of patients and seriously interfering with active therapy, quality of life, and survival time. There are
currently no effective treatments for cachexia. Therefore, new therapeutic strategies are required. In recent
years, advances in understanding the mechanisms underlying cachexia have been made, and new drugs
have been developed to combat cachexia muscle wasting and weight loss due to cancer. In this systematic
review, we discuss these novel targets and drug treatments. |
| Close |
|
|
|